The role of hepatic lipase in lipoprotein metabolism and atherosclerosis

Current Opinion in Lipidology

Volumn 9, Issue 3, 1998, Pages 211-219

  Santamarina Fojo, Silvia ^a   Haudenschild, Changting ^a   Amar, Marcelo ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHOLIPID; PROTEOGLYCAN; TRIACYLGLYCEROL;

ANIMAL CELL; ATHEROSCLEROSIS; DRUG HYDROLYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIGAND BINDING; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; HUMANS; LIPASE; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEINS; LIVER; MODELS, BIOLOGICAL; PROTEOGLYCANS; RECEPTORS, CELL SURFACE;

ANIMALIA;

EID: 0031748544     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199806000-00005     Document Type: Review

References (76)

1. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 1995; 6:291-305.
2. Applebaum-Bowden D. Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 1995; 6:130-135.
3. Bensadoun A, Berryman DE. Genetics and molecular biology of hepatic lipase. Curr Opin Lipidol 1996;7:77-81.
4. Kuusi T, Kinnunen PK, Nikkilä EA. Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo. FEBS Lett 1979; 104:384-388.
5. Jansen H, van Tol A, Hulsmann WC. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun 1980, 92:53-59.
6. Grosser J, Schrecker O, Greten H. Function of hepatic triglyceride lipase in lipoprotein metabolism. J Lipid Res 1981; 22:437-442.
7. Murase T, Itakura H. Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats. Atherosclerosis 1981; 39:293-300.
8. Daggy BP, Bensadoun A. Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase. Biochim Biophys Acta 1986; 877:252-261.
9. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res 1994; 35:709-720.
10. Goldberg IJ, Le NA, Patemiti JR Jr, Ginsberg HN, Lindgren FT, Brown WV. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982, 70:1184-1192.
11. Sultan F, Lagrange D, Jansen H, Griglio S. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim Biophys Acta 1990; 1042:150-152.
12. Demacker PN, Hijmans AG, Stalenhoef AF, Van't Laar A. Studies on the function of hepatic lipase in the cat after immunological blockade of the enzyme in vivo. Atherosclerosis 1988; 69:173-183.
13. Marques-Vidal P, Azéma C, Collet X, Vieu C, Chap H, Perret B. Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: A study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res 1994; 35:373-384.
14. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G, Lindgren F, Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 1982; 45:161-179.
15. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, et al. Hepatic lipase deficiency: Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 1993; 13:720-728.
16. Carlson LA, Holmquist L, Nilsson-Ehle P. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-α-triglyceridemia. Acta Med Scand 1986; 219:435-447.
17. Auwerx JH, Babirak SP, Hokanson JE, Stahnke G, Stahnke G, Will H, et al. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet 1990; 46:470-477.
18. Knudsen P, Antikainen M, Uusi-Oukari M, Ehnholm S, Lahdenpera S, Bensadoun A, et al. Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis 1997; 128:165-174.
19. Brand K, Dugi KA, Brunzell JD, Nevin DN, Brewer HB, Jr, Santamarina-Fojo S. A novel A-G mutation in intron 1 of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res 1996; 37:1213-1223.
20. Knudsen P, Antikainen M, Ehnholm S, Uusi-Oukari M, Tenkanen H, Lahdenpera S, et al. A compound heterozygote for hepatic lipase gene mutations Leu334 → Phe and Thr383 → Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res 1996; 37:825-834.
21. Homanics GE, De Silva HV, Osada J, Zhang SH, Wong H, Borensztajn J, Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem 1995; 270:2974-2980.
22. Applebaum-Bowden D, Kobayashi J, Kashyap VS, Brown DR, Berard AM, Meyn S, et al. Hepatic lipase gene therapy in hepatic lipase-deficient mice: adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium. J Clin Invest 1996; 97:799-805.
23. Busch SJ, Bamhart RL, Martin GA, Fitzgerald MC, Yates MT, Mao SJT, et al. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem 1994; 269:16376-16382.
24. Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA 1994; 91:8724-8728.
25. Dugi KA, Vaisman BL, Sakai N, Knapper CL, Meyn SM, Brewer HB, Jr, Santamarina-Fojo S. Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J Lipid Res 1997; 38:1822-1832.
26. Vaisman BL, Klein H-G, Rouis M, Berard AM, Kindt MR, Talley GD, et al. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J Biol Chem 1995; 270:12269-12275.
27. Dugi KA, Dichek HL, Talley GD, Brewer HB, Jr, Santamarina-Fojo S. Human lipoprotein lipase: the loop covering the catalytic site is essential for interaction with lipid substrates. J Biol Chem 1992; 267:25086-25091.
28. Dugi KA, Dichek HL, Santamarina-Fojo S. Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity. J Biol Chem 1995; 270:25396-25401.
29. Kobayashi J, Applebaum-Bowden D, Dugi KA, Brown D, Kashyap V, Parrott C, et al. Analysis of protein structure-function in vivo: adenovirus-mediated transfer of lipase mutants in hepatic lipase deficient mice. J Biol Chem 1996; 271:26296-26301. LpL lids are exchanged. This study demonstrates the feasibility of performing structure-function analysis of proteins in vivo using recombinant adenovirus.
30. Felts JM, Itakura H, Crane RT. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants - a new theory. Biochem Biophys Res Commun 1975; 66:1467-1475.
31. Krapp A, Ahle S, Kersting S, Hua Y, Kneser K, Nielsen M, et al. Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J Lipid Res 1996; 37:926-936. This manuscript provides evidence supporting a role of HL in cellular chylomicron and β-VLDL uptake via LRP. Crosslinking experiments confirm binding of HL to LRP and competition studies indicate that lipoproteins most likely interact with the carboxyl-terminal domain of HL.
32. Ji Z-S, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biolog Chem 1994; 269:13429-13436.
33. Diard P, Malewiak M-I, Lagrange D, Griglio S. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem J 1994; 299:889-894.
34. Ji Z-S, Dichek HL, Miranda RD, Mahley RW. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem 1997; 272:31285-31292. The role of proteoglycans and RAP sensitive pathway(s) as well as catalytically inactive hepatic lipase in mediating the uptake of β-VLDL, IDL and HDL is evaluated in transfected rat hepatoma cells. Evidence that hepatic lipase enhances both direct uptake of HDL particles and selective uptake of HDL cholesteryl esters via different pathways is provided.
35. Komaromy M, Azhar S, Cooper AD. Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. J Biol Chem 1996; 271:16906-11914. This study emphasizes the importance of hepatic lipase in promoting lipoprotein clearance via multiple pathways by demonstrating that it enhances LDL as well as selective uptake of HDL-CE but not chylomicron remnants in transfected CHO cells stably expressing hepatic lipase.
36. Choi SY, Komaromy MC, Chen J, Fong LG, Cooper AD. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J Lipid Res 1994; 35:848-859.
37. Kounnas MZ, Chappell DA, Wong H, Argraves WS, Strickland DK. The cellular internalization and degradation of hepatic lipase in mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J Biol Chem 1995; 270:9307-9312.
38. Bamberger M, Glick JM, Rothblat GH. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J Lipid Res 1983; 24:869-876.
39. Kadowaki H, Patton GM, Robins SJ. Metabolism of high density lipoprotein lipids by the rat liver: Evidence for participation of hepatic lipase in the uptake of cholesteryl ester. J Lipid Res 1992; 33:1689-1698.
40. Collet X, Perret BP, Simard G, Vieu C. Douste-Blazy L. Behaviour of phospholipase-modified HDL towards cultured hepatocytes. I. Enhanced transfers of HDL sterols and apoproteins. Biochim Biophys Acta 1990; 1043:301-310.
41. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520. This paper represents a major breakthrough in the HDL receptor field. The authors identify and characterize the murine scavenger receptor, SR-BI, which mediates the selective uptake of cholesteryl esters from HDL.
42. Wang N, Weng W, Breslow JL, Tall AR. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. J Biol Chem 1996; 271:21001-21004. Evidence that SR-BI expression is regulated by intracellular cholesterol is provided by analysis of adrenal SR-BI mRNA in apoA-I and hepatic lipase deficient mice with decreased cholesterol adrenal stores.
43. Amar MJ, Shamburek RD, Maeda N, Kindt MR, Santamarina-Fojo S, Brewer HB, Jr. Adenovirus mediated expression of hepatic lipase in apoE deficient mice: evidence for hepatic lipase-mediated clearance of remnant lipoprotein. Circulation 1996; 94:1-398. Adenovirus-mediated transient expression of native and catalytically inactive hepatic lipase in apoE deficient mice provides in-vivo evidence for a role of hepatic lipase in remnant lipoprotein metabolism independent of lipolysis.
44. de Faria E, Fong LG, Komaromy M, Cooper AD. Relative roles of the LDL receptor, the LDL receptor-like protein, hepatic lipase in chylomicron remnant removal by the liver. J Lipid Res 1996; 37:197-209. Infusion of anti-LDL receptor antibodies, anti-hepatic lipase antibodies and RAP in mice provides in-vivo evidence that supports a role of the LDL receptor and other RAP sensitive pathways as well as hepatic lipase chylomicron remnant removal by the liver.
45. Haudenschild CC, Dugi KA, Amar MJ, Knapper CL, Bensadoun A, Maeda N, et al. Identification of a residue (433 K) essential for hepatic lipase mediated remnant lipoprotein metabolism independent of lipolysis. Circulation 1997; 96:1-38. Adenovirus-mediated expression of catalytically active but binding defective hepatic lipase (HL433Q) in apoE and hepatic lipase deficient mice provides evidence that hepatic lipase-lysine 433 and LRP are involved in the clearance of chylomicron remnants through nonlipolytic pathways in vivo.
46. Dugi KA, Knapper CL, Applebaum-Bowden D, Bensadoun A, Meyn SM, Le TT, Maeda N, Brewer HB. Jr, Santamarina-Fojo S. In vivo evidence for a nonlipolytic role of hepatic lipase in the metabolism of high density lipoprotein. Circulation 1996; 94:1-398. Adenovirus-mediated expression of native and catalytically inactive hepatic lipase in hepatic lipase deficient mice establish the importance of both lipolytic and nonlipolytic roles of hepatic lipase in HDL metabolism in vivo.
47. Dichek HL, Brecht W, Fan J, Ji J-S, McCormick SPA, Akeefe H, et al. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. J Biol Chem 1998; 273:1896-1903. Expression of native and catalytically inactive hepatic lipase in apoE deficient mice provides in-vivo evidence that it can act as a ligand to enhance the clearance of apoB-containing lipoproteins.
48. Rohlmann A, Gotthardt M, Hammer RE, Herz J. Inducible inactivation of hepatic LRP gene by pre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 1998; 101:689-695. Tissue-specific disruption of the LRP gene in the liver of LDL receptor deficient mice establishes the physiological role of LRP in the clearance of chylomicron remnants in vivo.
49. 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J Biol Chem 1994; 269:8653-8658.
50. Azhar S, Cooper A, Tsai L, Maffe W, Reaven E. Characterization of apoB, E receptor function in the luteinized ovary Palo Alto, CA 94305. J Lipid Res 1988; 29:869-882.
51. Green SR, Pittman RC. Selective uptake of cholesteryl esters from low density lipoproteins in vitro and in vivo. J Lipid Res 1991; 32:667-678.
52. Brissette L, Falstrault L. Analysis of the binding and association of human intermediate density lipoproteins to HepG2 cells. Biochim Biophys Acta Lipids Lipid Metab 1992; 1165:84-92.
53. Brissette L, Falstrault L. Analysis of the selective uptake of the cholesteryl ester of human intermediate density lipoproteins to HepG2 cells. Biochim Biophys Acta Lipids Lipid Metab 1994; 1213:5-13.
54. Brissette L, Falstrault L, Lafond J, Izem L. The selective uptake of the cholesteryl esters of low density lipoproteins parallels the activity of protein kinase C. Biochem Arch 1996; 1301:133-140.
55. Rinninger F, Brundert M, Jackle S, Kaiser T, Greten H. Selective uptake of low-density lipoprotein-associated cholesterol esters by human fibroblasts, human HepG2 hepatoma cells and J774 macrophages in culture. Biochem Biophys Acta 1995; 1255:144-153.
56. Hirano K-I, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, et al. Atherosclerotic disease in marked hyperalphalipoproteinemia: combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 1995; 15:1849-1856.
57. Groot PHE, Van Stiphout WAHJ, Krauss XH, Jansen H, von Tol A, Van Ramshorst E. et al. Postprandial lipoprotein metabolism in normalipidemic men with and without coronary artery disease. Arteriosclerosis 1991; 11:653-662.
58. Dugi KA, Feuerstein IM, Hill S, Shih J, Santamarina-Fojo S, Brewer HB, Jr, Hoeg JM. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997; 17:354-364.
59. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997; 17:2837-2842.
60. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; 1:16-19.
61. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 1989; 321:1311-1316.
62. Hausmann D, Johnson JA, Sudhir K, Mullen WL, Friedrich G, Fitzgerald PJ. et al. Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemla: correlation with high density lipoproteins. J Am Coll Cardiol 1996; 27:1562-1570. Recent study that evaluates the extent of atherosclerosis in coronary and iliac arteries in patients with heterozygous familial hypercholesterolemia and familial hyperlipidemia using intravascular ultrasound. Levels of HDL and total/HDL cholesterol ratio were the most powerful predictors of coronary plaque burden in these patients.
63. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997; 17:107-113. Recent study examining coronary heart disease and all cause mortality of 8000 Israeli men. Coronary heart disease mortality in men with low HDL level (<0.9mmol/L) was 36% higher than in counterparts with HDL >0.9 the mmol/L. This study provides further data to support an inverse correlation between plasma HDL levels and atherosclerosis.
64. 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80:341-347.
65. Kuusi T, Ennholm C, Viikari J, Harkonen R, Vartiainen E, Puska P, Taskinen MR. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 1989; 30:1117-1126.
66. Jackson RL, Yates MT, McNemey CA, Kashyap ML. Relationship between post-heparin plasma upases, triglycerides and high density lipoproteins in normal subjects. Cincinnati College of Medicine, Ohio. Horm Metab Res 1990; 22:289-294.
67. Applebaum-Bowden D, Haffmer SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Postheparin plasma triglyceride upases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein cholesterol. Arteriosclerosis 1987; 5:273-282.
68. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb Vasc Biol 1993; 13:1227-1235.
69. Colvin PL, Jr, Auerbach BJ, Case LD, Hazzard WR, Applebaum-Bowden D. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. Metabolism 1991; 40:1052-1056.
70. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994; 94:2377-2384.
71. Guerra R, Wang J, Grundy SM, Cohen JC, A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Nalt Acad Sci USA 1997; 94:4532-4537.
72. Vega GL, Clark LT, Tang AM, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African-American men than in white American men effects of 5′-flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998; 39:228-232.
73. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb Vasc Biol 1993; 13:147-153.
74. Mezdour H, Jones R, Dengremont C, Castro G, Maeda N. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem 1997; 272:13570-13575. Hepatic lipase deficiency in female apoE deficient mice leads to significant increases in plasma cholesterol, β-VLDL and HDL concentrations as well as reductions in aortic atherosclerosis. HDL from apoE and hepatic lipase deficient mice had increased capacity to promote cholesterol efflux. These findings suggest that hepatic lipase may modulate the development of atherosclerosis by alternative pathways independent of changes in the plasma lipid profile.
75. Amar MJ, Vaisman BL, Foger B, Paigen B, Talley GD, Brewer HB, Jr, Santamarina-Fojo S. The effect of hepatic lipase deficiency on the plasma lipids, lipoproteins and diet-induced atherosclerosis in LCAT transgenic mice. Circulation 1997; 96:1-109. Hepatic lipase deficiency abolishes diet-induced aortic atherosclerosis in LCAT transgenic mce despite significant increases in plasma cholesterol concentrations. These findings suggest that hepatic lipase may modulate the development of atherosclerosis by alternative pathways independent of changes in the plasma lipid profile.
76. Aviram M, Bierman EL, Chait A. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem 1988; 263:15416-15422.